Effectiveness of electronic drug monitoring feedback to increase adherence in patients with RA initiating a biological DMARD: a randomised clinical trial.
Renske C F HebingIremnur AksuJos Wr TwiskWouter BosBart Van den BemtMichael T NurmohamedPublished in: RMD open (2022)
EMF increased adherence for patients with RA starting with or switching to a bDMARD. Especially bDMARD-naive patients achieved LDA sooner compared with the control group, which holds promise for the future.
Keyphrases
- clinical trial
- end stage renal disease
- rheumatoid arthritis
- newly diagnosed
- open label
- ejection fraction
- randomized controlled trial
- chronic kidney disease
- systematic review
- double blind
- study protocol
- peritoneal dialysis
- prognostic factors
- disease activity
- hiv infected
- ankylosing spondylitis
- patient reported outcomes
- phase ii
- systemic lupus erythematosus
- current status
- machine learning
- skeletal muscle
- insulin resistance
- systemic sclerosis